Histone Deacetylase Inhibitors in Cancer: What Have We Learned?

作者：Whittle James R; Desai Jayesh^*

来源：Cancer, 2015, 121(8): 1164-1167.

DOI：10.1002/cncr.29177

The authors outline the current stage in the development of histone deacetylase inhibitors in solid tumors. Despite single-agent benefit in a small number of hematologic malignancies, evidence in solid organ cancers suggests that outcomes will be more promising with combination therapy and should be the focus of future studies.

• 出版日期2015-4-15
• 单位河北医科大学